M14-239
ClinicalTrials.gov NCT03539536
Research payments
$1,282,529
Through program year 2020, $1,282,529 in research payments was reported against M14-239, across 211 payments, paid by AbbVie, Inc..
- Paid by
- AbbVie, Inc.
- ClinicalTrials.gov
- NCT03539536
By program year
2 rows| Year | Kind | Amount | Payments |
|---|---|---|---|
| 2020 | Research | $845,988 | 146 |
| 2019 | Research | $436,541 | 65 |
Breakdown
Usually the institution or organisation running the study, not a person.
Records
Every payment, record by record
Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.
Principal investigators named
8 shownNamed on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.
- David Camidge Aurora, CO Named on 28 payments
- Rachel Sanborn Portland, OR Named on 26 payments
- John Hamm Louisville, KY Named on 17 payments
- Jonathan Thompson Milwaukee, WI Named on 14 payments
- William Moore Setauket, NY Named on 11 payments
- Michael Reiter Stony Brook, NY Named on 11 payments
- Leora Horn Nashville, TN Named on 9 payments
- Christina Baik Seattle, WA Named on 8 payments
What you are looking at
Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.